Precision Biosciences (DTIL) Long-Term Investments (2021 - 2026)

Precision Biosciences (DTIL) has 6 years of Long-Term Investments data on file, last reported at $744000.0 in Q1 2026.

• On a quarterly basis, Long-Term Investments fell 76.79% year-over-year to $744000.0 in Q1 2026; TTM through Mar 2026 was $744000.0, a 76.79% decrease from a year earlier, with the FY2025 full-year figure at $744000.0, down 76.79% from the prior year.
• Long-Term Investments for Q1 2026 stood at $744000.0, roughly flat from $744000.0 in the prior quarter.
• Over the last five years, Long-Term Investments for DTIL reached as high as $3.2 million in Q4 2023 and fell as low as $744000.0 in Q2 2025.
• Historically, Long-Term Investments has averaged $2.3 million across 5 years, with a median of $3.1 million in 2022.
• Across the five-year window, Long-Term Investments soared 280.67% in 2022 and tumbled 76.79% in 2025, its largest moves.
• Year by year, Long-Term Investments stood at $2.6 million in 2022, then gained by 24.46% to $3.2 million in 2023, then changed by 0.0% to $3.2 million in 2024, then tumbled by 76.79% to $744000.0 in 2025, then changed by 0.0% to $744000.0 in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $744000.0 in Q1 2026, $744000.0 in Q4 2025, and $744000.0 in Q3 2025.